Gemelli Biotech announced today that its diagnostic technologies will be featured across multiple research presentations at DDW 2026, the world's premier gathering of gastrointestinal researchers and ...
SAN DIEGO--(BUSINESS WIRE)--Gemelli Biotech, in partnership with the Medically Associated Science and Technology (MAST) program at Cedars-Sinai, announced new findings that validate a ...
LOS ANGELES & RALEIGH, N.C.--(BUSINESS WIRE)--Gemelli Biotech, producers of the ibs-smart™ blood test for irritable bowel syndrome with a diarrheal component (IBS-D and IBS-M), announced the ...
Gemelli Biotech's ibs -smart blood test for IBS patients is now commercially available. Here are the key details to know: 1. The ibs-smart test measures two antibodies, anti-CdtB and anti-vinculin, in ...
The test works by measuring levels of anti-cytolethal distending toxin B (CdtB) and anti-vinculin, 2 biomarkers of post-infectious IBS-D and IBS-M. Gemelli Biotech has announced the launch of ...
IRVINE, Calif., April 17, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic products, is pleased to announce that inFoods® IBS, ...
Biomerica applies for a PLA code to enhance patient access to its inFoods IBS diagnostic test for personalized IBS management. Biomerica, Inc. has submitted an application to the American Medical ...
Mark Gurarie is a writer covering health topics, technology, music, books, and culture. He also teaches health science and research writing at George Washington University's School of Medical and ...
Hosted on MSN
Taming IBS with smart food and lifestyle choices
IBS is a growing concern, especially among stressed professionals, but relief is possible through personalised diets, fibre management, and lifestyle changes. Experts highlight that approaches like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results